Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
7h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
9h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
10h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
18h agoBuffalo Potash Files Annual Information Form and New Technical Report
19h agoIonik Announces 30-Day Extension of Senior Debt Facility
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

About

4.52USD-0.02 -0.44%
Closed • Updated at 21:57 GMT+00:00
Market Cap$631.28M
Volume627.7K
Beta1.06
RSI51.47
Gross Margin9.69%
Health TechnologyPharmaceuticals: Major

Aclaris Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 8 2026
Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference
May 7 2026
Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update
Apr 28 2026
Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead Indicati...
Apr 27 2026
Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026
Apr 8 2026
Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference

Community Chat

Ask AI

Try asking
6ix6ixAIEvents